GSK
GSK
GSK
740 hedge funds and large institutions have $9.13B invested in GSK in 2016 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 297 increasing their positions, 238 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
0.14% less ownership
Funds ownership: 3.61% → 3.47% (-0.14%)
4% less capital invested
Capital invested by funds: $9.53B → $9.13B (-$401M)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
Holders
740
Holding in Top 10
9
Calls
$163M
Puts
$94M
Top Buyers
| 1 | +$60.7M | |
| 2 | +$33.8M | |
| 3 | +$30.8M | |
| 4 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$25.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$23.3M |
Top Sellers
| 1 | -$173M | |
| 2 | -$153M | |
| 3 | -$76.8M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$54.3M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$33M |